108 related articles for article (PubMed ID: 24735105)
1. Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.
Vadaparampil ST; Scherr CL; Cragun D; Malo TL; Pal T
Clin Genet; 2015 May; 87(5):473-7. PubMed ID: 24735105
[TBL] [Abstract][Full Text] [Related]
2. A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Pal T; Cragun D; Lewis C; Doty A; Rodriguez M; Radford C; Thompson Z; Kim J; Vadaparampil ST
Genet Test Mol Biomarkers; 2013 May; 17(5):367-75. PubMed ID: 23448386
[TBL] [Abstract][Full Text] [Related]
3. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
4. Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
Kahn RM; Ahsan MD; Chapman-Davis E; Holcomb K; Nitecki R; Rauh-Hain JA; Fowlkes RK; Tubito F; Pires M; Christos PJ; Tkachuk K; Krinsky H; Sharaf RN; Offit K; Lipkin S; Frey MK
Fam Cancer; 2023 Apr; 22(2):127-133. PubMed ID: 36207653
[TBL] [Abstract][Full Text] [Related]
5. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland.
Stefansdottir V; Thorolfsdottir E; Hognason HB; Patch C; van El C; Hentze S; Cordier C; Mendes Á; Jonsson JJ
Eur J Hum Genet; 2020 Dec; 28(12):1656-1661. PubMed ID: 32523053
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported hereditary breast and ovarian cancer in a primary care practice.
Quillin JM; Krist AH; Gyure M; Corona R; Rodriguez V; Borzelleca J; Bodurtha JN
J Community Genet; 2014 Apr; 5(2):179-83. PubMed ID: 23872790
[TBL] [Abstract][Full Text] [Related]
7. The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing?
Campacci N; Grasel RS; Galvão HCR; Garcia LF; Ribeiro PC; Pereira KFJS; Goldim JR; Ashton-Prolla P; Palmero EI
Front Psychol; 2024; 15():1306388. PubMed ID: 38500651
[TBL] [Abstract][Full Text] [Related]
8. Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations.
Mittendorf KF; Kauffman TL; Amendola LM; Anderson KP; Biesecker BB; Dorschner MO; Duenas DM; Eubanks DJ; Feigelson HS; Gilmore MJ; Hunter JE; Joseph G; Kraft SA; Lee SSJ; Leo MC; Liles EG; Lindberg NM; Muessig KR; Okuyama S; Porter KM; Riddle LS; Rolf BA; Rope AF; Zepp JM; Jarvik GP; Wilfond BS; Goddard KAB;
Contemp Clin Trials; 2021 Jul; 106():106432. PubMed ID: 33984519
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
Bednar EM; Chen M; Walsh MT; Eppolito AL; Klein MH; Teed K; Hodge B; Hunter J; Chao HG; Davis D; Serchion W; Yobbi C; Krukenberg R; Jenkinson SB; Moore JJ; Garcia C; Gonzalez F; Murray T; Nielsen LD; Ho B; Haas M; Greenzweig SB; Anderson A; Johnson C; Morman NA; Bowdish E; Wise E; Cooper JN; Russ PK; Tondo-Steele K; de Gracia BF; Levin B; Mattie K; Zarnawski K; Kalasinski M; Stone J; O'Brien C; Bream A; Kennedy AM; Paul RA; Bilbao M; Romero M; Carr RL; Siettmann JM; Vercruyssen AK; Leon K; Arun BK; Grainger AV; Warshal DP; Bowman E; Goedde TA; Halaharvi D; Rath K; Grana G; Mina L; Lu KH
Gynecol Oncol; 2023 May; 172():106-114. PubMed ID: 37004303
[TBL] [Abstract][Full Text] [Related]
10. Group plus "mini" individual pre-test genetic counselling sessions for hereditary cancer shorten provider time and improve patient satisfaction.
Hynes J; MacMillan A; Fernandez S; Jacob K; Carter S; Predham S; Etchegary H; Dawson L
Hered Cancer Clin Pract; 2020; 18():3. PubMed ID: 32099586
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Hereditary Breast Cancer Genetic Services: Are Changes Reflected in the Knowledge and Clinical Practices of Florida Providers?
Cragun D; Scherr C; Camperlengo L; Vadaparampil ST; Pal T
Genet Test Mol Biomarkers; 2016 Oct; 20(10):569-578. PubMed ID: 27525501
[TBL] [Abstract][Full Text] [Related]
12. Characteristics associated with genetic counseling referral and BRCA1/2 testing among women in a large integrated health system.
Bellcross CA; Peipins LA; McCarty FA; Rodriguez JL; Hawkins NA; Hensley Alford S; Leadbetter S
Genet Med; 2015 Jan; 17(1):43-50. PubMed ID: 24946155
[TBL] [Abstract][Full Text] [Related]
13. Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium.
Nakamura S; Kwong A; Kim SW; Iau P; Patmasiriwat P; Dofitas R; Aryandono T; Hu Z; Huang CS; Ginsburg O; Rashid MU; Sarin R; Teo SH
Public Health Genomics; 2016; 19(1):53-60. PubMed ID: 26575363
[TBL] [Abstract][Full Text] [Related]
14. Differences in BRCA counseling and testing practices based on ordering provider type.
Cragun D; Camperlengo L; Robinson E; Caldwell M; Kim J; Phelan C; Monteiro AN; Vadaparampil ST; Sellers TA; Pal T
Genet Med; 2015 Jan; 17(1):51-7. PubMed ID: 24922460
[TBL] [Abstract][Full Text] [Related]
15. Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.
Rodgers-Fouche L; Arora S; Ricker C; Li D; Farooqi M; Balaguer F; Dominguez-Valentin M; Guillem JG; Kanth P; Liska D; Melson J; Mraz KA; Shirts BH; Vilar E; Katona BW; Hodan R
JCO Precis Oncol; 2023 Sep; 7():e2300440. PubMed ID: 37897815
[TBL] [Abstract][Full Text] [Related]
16. Combining clinical and molecular characterization of CDH1: a multidisciplinary approach to reclassification of a splicing variant.
Fillman C; Anantharajah A; Marmelstein B; Dillon M; Horton C; Peterson C; Lopez J; Tondon R; Brannan T; Katona BW
Fam Cancer; 2023 Oct; 22(4):521-526. PubMed ID: 37540482
[TBL] [Abstract][Full Text] [Related]
17. Missed diagnosis or misdiagnosis: Common pitfalls in genetic testing.
Shaw T; Fok R; Courtney E; Li ST; Chiang J; Ngeow J
Singapore Med J; 2023 Jan; 64(1):67-73. PubMed ID: 36722519
[TBL] [Abstract][Full Text] [Related]
18. Adapting a Theoretically-Based intervention for underserved clinical populations at increased risk for hereditary Cancer: Lessons learned from the
Hurtado-de-Mendoza A; Reyna VF; Wolfe CR; Gómez-Trillos S; Sutton AL; Brennan A; Sheppard VB
Prev Med Rep; 2022 Aug; 28():101887. PubMed ID: 35855922
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
